CIK 0001178670 · Large accelerated filer
ALNYLAM PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ALNY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 770602661
- Phone
- (617) 551-8200
- Business address
- 675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142
- Former names
- ALNYLAM PHARMACEUTICALS INC
- 4 Insider Changes in Ownership
- 8-K Event Material agreement
- ARS Other Annual Report to Security Holders
- 4 Insider Changes in Ownership
- DEF 14A Proxy Proxy Statement
- 3 Insider Initial Statement of Ownership
- UPLOAD Other SEC-generated Letter
- UPLOAD Other SEC-generated Letter
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K Event Results of operations
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Executive or director change
- SC 13G Stake Amended Statement of Ownership
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K Event Material agreement
- CORRESP Other Correspondence Between Filers and SEC Staff
Page 69 of 85 · 1,688 filings